Find a TenderAwarded without competitionContract details notice
Published 16 Feb 2026, 15:13 GMT

Official UK procurement notice

Biorepository and Processing services

Official notice

Authority: GENOMICS ENGLAND LIMITED (Central government)

Direct award
Sectors: Health & Social Care (85) Delivery: Delivery location not published
Awarded value£1,843,498published award · exc. VAT
Awarded 23 Feb 2026no call for competition
Awarded to Uk Biocentre Ltd

What is being bought

Published requirement description

The services cover end‑to‑end management of biological samples, including receipt, verification and secure storage in controlled ultra‑low‑temperature environments. Samples are processed through a range of laboratory workflows that include DNA and RNA extraction, quality control testing, normalisation, and preparation for downstream sequencing all delivered on a per‑sample basis, there is no fixed maximum number of samples. Additional activities include aliquoting, pooling, reformatting into required labware, and arranging shipments to designated laboratories. Project‑specific workflows may be developed to meet bespoke requirements.

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
16 Feb 2026, 15:13 GMT
Last source update
2 Oct 2026, 13:29 BST
Authority reference
GEL-HE-25732
FTS notice number
2026/S 000-093354
Latest notice
Contract details notice (UK7)
Delivery area
Not published
Official registry OCID
ocds-h6vhtk-065523 Find a Tender
Why no open competition
Additional Repeat Extension Partial Replacement
Published justification

The delivery of services under a new contract with the existing supplier is proposed in accordance with Schedule 5, Paragraph 7 of the Procurement Act 2023, which enables a direct award where a change of supplier would result in incompatible goods or services and where such incompatibility would give rise to disproportionate technical difficulties in operation or maintenance. The remaining activity represents a continuation of established work already underway within the programme, and the new contractual arrangement does not introduce any additional or materially altered services.

Transitioning to an alternative supplier at this stage would require substantial changes to embedded methodologies, operational processes and systems integration, resulting in significant incompatibilities with the established technical approach. Crucially, a change of supplier would also necessitate the transportation of a substantial volume of biological samples to a new provider. This introduces a material and unacceptable risk of contamination, loss, degradation or compromise of sample integrity, given the heightened handling requirements, increased logistical steps, and the sensitivity of the sample types involved. Such risks would directly threaten the comparability, consistency and scientific validity of programme outputs.

Managing these transportation risks-alongside the need to migrate complex datasets, workflows and sample handling processes-would introduce disproportionate technical difficulties, as anticipated under Schedule 5, Paragraph 7, and would undermine the robustness of the study's established operational and analytical frameworks. Maintaining service delivery with the incumbent supplier therefore ensures continuity of technical methodologies, operational processes and quality controls, safeguarding the reliability and stability of the remaining programme work.

In these circumstances, awarding a new contract to the existing supplier meets the criteria under Schedule 5, Paragraph 7, as a change in supplier would result in incompatible services and introduce unreasonable and disproportionate technical and logistical difficulties. The direct award is therefore the most appropriate, proportionate and compliant procurement route under the Procurement Act 2023.

How it was run

Official notice
Submission deadline
—

Timeline

4 Mar 2026 → 2 Oct 2026 · 2 dates
  1. Standstill ends226 days ago
    4 Mar 2026, 23:59 GMT
  2. Notice published15 days ago
    2 Oct 2026, 13:29 BST

Notice history

4 events · 3 releases on Find a Tender · since 16 Feb 2026
  1. Transparency notice published
    16 Feb 2026, 15:13 GMT
    UK5
  2. Contract award notice published
    23 Feb 2026, 10:59 GMT
    UK6
  3. Contract signature expected
    27 Mar 2026, 23:59 GMT
    scheduled
  4. Contract details notice published
    2 Oct 2026, 13:29 BST
    UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £1,843,4981 award exc. VAT
Contracts signed 1latest 30 Sept 2026
Awarded toValueDateStatus
Uk Biocentre Ltd1 Apr 2026 – 31 Mar 2028Options: The contract does not provide an automatic or unilateral right to make additional purchases; however, it does enable further services or increased volumes to be added through its formal Change Control procedure. Under the formal Change Control Procedure, any expansion of scope-such as additional processing, storage capacity, new workflows, or increased sample batching volumes-must be requested, assessed, and mutually agreed by both parties before becoming contractually binding. This mechanism allows the Authority to procure additional work when needed but only through a structured and approved variation to the existing services.£1,843,49823 Feb 2026Awarded

Contracts

  • GEL-HE-25372 Biorepository and Processing services · Uk Biocentre Ltd

    Signed
    30 Sept 2026
    Value
    £1,843,498
    Period
    30 Sept 2026 – 31 Mar 2028
    Status
    active
    Options
    The contract does not provide an automatic or unilateral right to make additional purchases; however, it does enable further services or increased volumes to be added through its formal Change Control procedure. Under the formal Change Control Procedure, any expansion of scope-such as additional processing, storage capacity, new workflows, or increased sample batching volumes-must be requested, assessed, and mutually agreed by both parties before becoming contractually binding. This mechanism allows the Authority to procure additional work when needed but only through a structured and approved variation to the existing services.

    No agreed KPIs: KPIs have been included within the contract, however the contract value does not reach the relevant threshold therefore publication is not necessary.

Contracting authority & participating public bodies

GENOMICS ENGLAND LIMITED

Contracting authorityPublic authority - central government GB-COH: 08493132 · GB-PPON: PBTW-5897-QJGY Level 21 One Canada Square, London, London, E14 5ABContact email

Bidders & participating suppliers

1 commercial party on the notice
  • UK BIOCENTRE LIMITEDAwarded supplierGB-COH: 07618653GB-PPON: PYHJ-9527-GHDD Units 2 & 3, Java Park Bradbourne Drive, Milton Keynes, South East, MK7 8ATContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

  • Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender
  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender